BACKGROUND:Nutritional intervention with hydrolysed infant formulas has been shown efficacious in preventing eczema in children predisposed to allergy. However, this preventive effect has never been related to the natural course of eczema in children with or without a family history of allergy. The aim of this study therefore was to compare the course of eczema in predisposed children after nutritional intervention to the natural course of eczema. METHOD: The prospective German birth cohort study GINIplus includes a total of 5991 children, subdivided into interventional and non-interventional groups. Children with a familial predisposition for allergy whose parents agreed to participate in the prospective, double-blind intervention trial (N=2252) were randomly assigned at birth to one of four formulas: partially or extensively hydrolysed whey, extensively hydrolysed casein (eHF-C) or standard cow's milk formula. Children with or without familial predisposition represented the non-interventional group (N=3739). Follow-up data were taken from yearly self-administered questionnaires from 1 up to 6 years. The outcome was physician-diagnosed eczema and its symptoms. The cumulative incidence of eczema in predisposed children with or withoutnutritional intervention was compared with that of non-predisposed children who did not receive intervention. Cox regression was used to adjust for confounding. RESULTS: Predisposed children without nutritional intervention had a 2.1 times higher risk for eczema [95% confidence interval (CI) 1.6-2.7] than children without a familial predisposition. The risk was smaller with nutritional intervention even levelling out to 1.3 (95% CI 0.9-1.9) in children fed eHF-C formula. CONCLUSION: Although direct comparability is somewhat restricted, the data demonstrate that early intervention with hydrolysed infant formulas can substantially compensate up until the age of 6 years for an enhanced risk of childhood eczema due to familial predisposition to allergy.
RCT Entities:
BACKGROUND: Nutritional intervention with hydrolysed infant formulas has been shown efficacious in preventing eczema in children predisposed to allergy. However, this preventive effect has never been related to the natural course of eczema in children with or without a family history of allergy. The aim of this study therefore was to compare the course of eczema in predisposed children after nutritional intervention to the natural course of eczema. METHOD: The prospective German birth cohort study GINIplus includes a total of 5991 children, subdivided into interventional and non-interventional groups. Children with a familial predisposition for allergy whose parents agreed to participate in the prospective, double-blind intervention trial (N=2252) were randomly assigned at birth to one of four formulas: partially or extensively hydrolysed whey, extensively hydrolysed casein (eHF-C) or standard cow's milk formula. Children with or without familial predisposition represented the non-interventional group (N=3739). Follow-up data were taken from yearly self-administered questionnaires from 1 up to 6 years. The outcome was physician-diagnosed eczema and its symptoms. The cumulative incidence of eczema in predisposed children with or without nutritional intervention was compared with that of non-predisposed children who did not receive intervention. Cox regression was used to adjust for confounding. RESULTS: Predisposed children without nutritional intervention had a 2.1 times higher risk for eczema [95% confidence interval (CI) 1.6-2.7] than children without a familial predisposition. The risk was smaller with nutritional intervention even levelling out to 1.3 (95% CI 0.9-1.9) in children fed eHF-C formula. CONCLUSION: Although direct comparability is somewhat restricted, the data demonstrate that early intervention with hydrolysed infant formulas can substantially compensate up until the age of 6 years for an enhanced risk of childhood eczema due to familial predisposition to allergy.
Authors: Anna Gref; Simon K Merid; Olena Gruzieva; Stéphane Ballereau; Allan Becker; Tom Bellander; Anna Bergström; Yohan Bossé; Matteo Bottai; Moira Chan-Yeung; Elaine Fuertes; Despo Ierodiakonou; Ruiwei Jiang; Stéphane Joly; Meaghan Jones; Michael S Kobor; Michal Korek; Anita L Kozyrskyj; Ashish Kumar; Nathanaël Lemonnier; Elaina MacIntyre; Camille Ménard; David Nickle; Ma'en Obeidat; Johann Pellet; Marie Standl; Annika Sääf; Cilla Söderhäll; Carla M T Tiesler; Maarten van den Berge; Judith M Vonk; Hita Vora; Cheng-Jian Xu; Josep M Antó; Charles Auffray; Michael Brauer; Jean Bousquet; Bert Brunekreef; W James Gauderman; Joachim Heinrich; Juha Kere; Gerard H Koppelman; Dirkje Postma; Christopher Carlsten; Göran Pershagen; Erik Melén Journal: Am J Respir Crit Care Med Date: 2017-05-15 Impact factor: 21.405
Authors: Christine L M Joseph; Dennis R Ownby; Suzanne L Havstad; Kimberly J Woodcroft; Ganesa Wegienka; Hugh MacKechnie; Edward Zoratti; Edward L Peterson; Christine C Johnson Journal: J Allergy Clin Immunol Date: 2011-04-01 Impact factor: 10.793
Authors: Marie Standl; Eva Lattka; Barbara Stach; Sibylle Koletzko; Carl-Peter Bauer; Andrea von Berg; Dietrich Berdel; Ursula Krämer; Beate Schaaf; Stefan Röder; Olf Herbarth; Anette Buyken; Tim Drogies; Joachim Thiery; Berthold Koletzko; Joachim Heinrich Journal: PLoS One Date: 2012-05-21 Impact factor: 3.240
Authors: Darina Czamara; Carla M T Tiesler; Gabriele Kohlböck; Dietrich Berdel; Barbara Hoffmann; Carl-Peter Bauer; Sibylle Koletzko; Beate Schaaf; Irina Lehmann; Olf Herbarth; Andrea von Berg; Bertram Müller-Myhsok; Gerd Schulte-Körne; Joachim Heinrich Journal: PLoS One Date: 2013-05-27 Impact factor: 3.240
Authors: E Thiering; J Cyrys; J Kratzsch; C Meisinger; B Hoffmann; D Berdel; A von Berg; S Koletzko; C-P Bauer; J Heinrich Journal: Diabetologia Date: 2013-05-11 Impact factor: 10.122
Authors: Ariane Batscheider; Sylwia Zakrzewska; Joachim Heinrich; Christina M Teuner; Petra Menn; Carl Peter Bauer; Ute Hoffmann; Sibylle Koletzko; Irina Lehmann; Olf Herbarth; Andrea von Berg; Dietrich Berdel; Ursula Krämer; Beate Schaaf; H-Erich Wichmann; Reiner Leidl Journal: BMC Health Serv Res Date: 2012-10-02 Impact factor: 2.655